VANCOUVER, British Columbia, Oct. 05, 2020 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that engineers have achieved new, much higher levels of resolving power using a new PCB design and the latest mosfet chip technology leading to the highest level of molecular specificity to date with its Cannabix FAIMS Beta 3.2 circuit. The Company also reports the design of a significantly more compact FAIMS circuit board, paving the way for a smaller device footprint relative to previous versions, enhancing portability. Cannabix is using its FAIMS technology to isolate and detect ∆9-tetrahydrocannabinol (“THC”), a non-volatile compound, in breath. The Cannabix FAIMS marijuana breathalyzer device uses ion mobility filtering techniques (related to mass spectrometry – the gold standard analytical technique for molecular detection). Cannabix Technologies is on the forefront in research and
Tobacco giant Altria made a very public splash with its $1.8 billion investment in recreational cannabis in 2019. Since buying in, the company has been much more quietly trying to claim a long-term stake in the marijuana industry by patenting cannabis technology, public records show.
In late February of this year, Altria, the parent company of cigarette brands including Marlboro and Parliament, filed two patent applications for vaporizer devices specifically designed for cannabis, according to United States Patent and Trademark Office filings.
The company is also the current owner on two older vaporizer patents from the same inventor filed earlier and acquired through a sale, a company spokesman said. Those patents also specifically mention cannabis.
The Altria cannabis devices have temperature controls meant to allow consumers to vaporize THC or CBD.
Anyone who has used, sold, studied or even read much about marijuana likely recognizes these acronyms as active ingredients in the plant.
But beyond intoxicating tetrahydrocannabinol (THC) and therapeutic cannabidiol (CBD), there exists a diverse array of chemicals believed to quietly interact — a phenomenon known as the ‘entourage effect’ — influencing how each unique cannabis strain makes people feel.
To date, the cannabis industry has collected remarkably little data about those lesser-known compounds, new University of Colorado Boulder research shows. But that same study, published this month in the journal PLOS ONE, suggests that a surprising scientific field could play an integral role in filling the knowledge gap.
“This paper provides a very early example of how applying advanced data science techniques could give us new insight into how this plant works,” said senior-author Brian Keegan, an assistant professor in the Department of Information Science.
The future of marijuana retail could mean more automation and shorter wait times as Colorado marijuana retailers change their business models during the COVID-19 pandemic.
The Green Solution, one of the state’s largest dispensary chains, has installed self-service kiosks in all 21 lobbies of its retail stores. Meanwhile, Boston-based Anna offers self-service marijuana purchasing lockers that operate similar to vending machines, which are currently available in stores owned by Starbuds and Strawberry Fields dispensaries.
The need to fulfill fast, self-service marijuana sales was actually being developed before the pandemic, but the minimal-contact vending machines and self-serve kiosks are becoming more popular in Colorado dispensaries as the pandemic continues. Both options limit the amount of time spent by customers in the dispensary, minimize person-to-person contact and allow for faster customer turnover rates.
“We have clients who have really enjoyed the convenience and feel like it’s created a level of safety for